IL131007A0 - Use of gastrointestinal lipase inhibitors - Google Patents

Use of gastrointestinal lipase inhibitors

Info

Publication number
IL131007A0
IL131007A0 IL13100798A IL13100798A IL131007A0 IL 131007 A0 IL131007 A0 IL 131007A0 IL 13100798 A IL13100798 A IL 13100798A IL 13100798 A IL13100798 A IL 13100798A IL 131007 A0 IL131007 A0 IL 131007A0
Authority
IL
Israel
Prior art keywords
lipase inhibitors
gastrointestinal lipase
gastrointestinal
inhibitors
lipase
Prior art date
Application number
IL13100798A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL131007(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL131007A0 publication Critical patent/IL131007A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
IL13100798A 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors IL131007A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (1)

Publication Number Publication Date
IL131007A0 true IL131007A0 (en) 2001-01-28

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13100798A IL131007A0 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Country Status (27)

Country Link
US (1) US6147108A (cs)
EP (1) EP1017408B1 (cs)
JP (1) JP2001509173A (cs)
KR (1) KR100479968B1 (cs)
CN (1) CN1154505C (cs)
AR (1) AR011106A1 (cs)
AT (1) ATE292975T1 (cs)
AU (1) AU740375B2 (cs)
BR (1) BR9807655A (cs)
CA (1) CA2278854C (cs)
CZ (1) CZ295567B6 (cs)
DE (1) DE69829763T2 (cs)
DK (1) DK1017408T3 (cs)
ES (1) ES2239799T3 (cs)
HU (1) HU230834B1 (cs)
ID (1) ID22650A (cs)
IL (1) IL131007A0 (cs)
ME (1) ME00578A (cs)
NO (1) NO324452B1 (cs)
NZ (1) NZ336755A (cs)
PL (1) PL191222B1 (cs)
PT (1) PT1017408E (cs)
RU (1) RU2201272C2 (cs)
TR (1) TR199901853T2 (cs)
WO (1) WO1998034630A1 (cs)
YU (1) YU34199A (cs)
ZA (1) ZA98753B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1017408B1 (en) * 1997-02-05 2005-04-13 F. Hoffmann-La Roche Ag Use of tethrahydrolipstatin in the treatment of diabetes type ii
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
DE60138333D1 (de) 2000-03-14 2009-05-28 Unilever Nv Variabele Domänen der schweren Kette eines Antikörpers gegen menschliche Ernährungslipasen und deren Verwendungen
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
AU2003236521A1 (en) 2002-06-13 2003-12-31 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
RU2248793C1 (ru) * 2003-11-13 2005-03-27 Лазебник Леонид Борисович Способ лечения стеатогепатитов
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
KR101276754B1 (ko) 2004-07-19 2013-06-19 바이오콘 리미티드 인슐린―올리고머 접합체，제형 및 이들의 용도
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US7822452B2 (en) 2004-08-11 2010-10-26 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
EP2036575B1 (en) * 2007-09-12 2010-08-18 Mader S.r.l. Pharmaceutical compositions for oral use for treating patients affected by obesity
WO2009050720A1 (en) * 2007-10-15 2009-04-23 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
US9241908B2 (en) 2007-10-16 2016-01-26 Biocon Limited Orally administrable solid pharmaceutical composition and a process thereof
WO2009111542A2 (en) 2008-03-04 2009-09-11 Glucolight Corporation Methods and systems for analyte level estimation in optical coherence tomography
WO2010042499A1 (en) * 2008-10-06 2010-04-15 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
JP2019515654A (ja) * 2016-03-16 2019-06-13 ザ ジェイ． デヴィッド グラッドストーン インスティテューツ 肥満及び／又は糖尿病を処置するための方法及び組成物、並びに候補処置薬剤を識別するための方法及び組成物
US20190022061A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang Statins (Atorvastatin) can lower blood sugar level in diabetic

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
EP1017408B1 (en) * 1997-02-05 2005-04-13 F. Hoffmann-La Roche Ag Use of tethrahydrolipstatin in the treatment of diabetes type ii

Also Published As

Publication number Publication date
YU34199A (sh) 2002-08-12
HUP0001014A2 (hu) 2000-08-28
DE69829763D1 (de) 2005-05-19
TR199901853T2 (xx) 1999-12-21
ES2239799T3 (es) 2005-10-01
NZ336755A (en) 2001-06-29
NO324452B1 (no) 2007-10-22
AR011106A1 (es) 2000-08-02
ME00578A (en) 2011-12-20
NO993717L (no) 1999-10-04
DK1017408T3 (da) 2005-08-01
CA2278854A1 (en) 1998-08-13
CZ295567B6 (cs) 2005-08-17
PT1017408E (pt) 2005-07-29
EP1017408A1 (en) 2000-07-12
WO1998034630A1 (en) 1998-08-13
EP1017408B1 (en) 2005-04-13
BR9807655A (pt) 2000-02-15
DE69829763T2 (de) 2006-04-13
CN1154505C (zh) 2004-06-23
US6147108A (en) 2000-11-14
CZ265199A3 (cs) 2000-02-16
AU740375B2 (en) 2001-11-01
HUP0001014A3 (en) 2000-12-28
HK1025251A1 (en) 2000-11-10
RU2201272C2 (ru) 2003-03-27
ID22650A (id) 1999-12-02
HU230834B1 (hu) 2018-07-30
PL191222B1 (pl) 2006-03-31
KR20000070733A (ko) 2000-11-25
ATE292975T1 (de) 2005-04-15
NO993717D0 (no) 1999-07-30
CA2278854C (en) 2014-03-04
CN1246798A (zh) 2000-03-08
AU6616998A (en) 1998-08-26
ZA98753B (en) 1998-08-05
PL334975A1 (en) 2000-03-27
KR100479968B1 (ko) 2005-03-30
JP2001509173A (ja) 2001-07-10

Similar Documents

Publication Publication Date Title
IL131007A0 (en) Use of gastrointestinal lipase inhibitors
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
IL137719A0 (en) Inhibitors of phospholipase enzymes
IL137718A0 (en) Inhibitors of phospholipase enzymes
PL341762A1 (en) Precursors of aspartil protease inhibitors
PL339738A1 (en) Novel lactamic inhibitors of metaloproteinases
ZA98376B (en) Sulfamide-metalloprotease inhibitors
PL331856A1 (en) Heterocyclic inhibitors of metaloprotease
PL327569A1 (en) Promedications of thrombosin inhibitors
AP9701054A0 (en) Inhibitors of cycteine protease
IL128226A0 (en) Hppd gene and inhibitors
HU0900792D0 (en) Use of renin-angiotensin inhibitors
PL337725A1 (en) Inhibitors of proteases
PL328665A1 (en) Inhibitors of serinic protease
ZA983065B (en) Inhibitors of protein farnesyltranferase
GB2346885B (en) Phospholipase inhibitor
PL328081A1 (en) Peptidic inhibitors of haematoblast proliferation
GB9700233D0 (en) Use of glycosidase inhibitors
GB9713139D0 (en) Use of enzymes
EP0904069A4 (en) PLA2 INHIBITORS OF ANGIOGENESIS
GB9703335D0 (en) Inhibitors
GB9725783D0 (en) Inhibitors
GB9713709D0 (en) Inhibitors
GB9709064D0 (en) Inhibitors
GB9727371D0 (en) Inhibitors

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired